Effect of the PTPN22 and INS risk genotypes on the progression to clinical type 1 diabetes after the initiation of ß-cell autoimmunity




Lempainen J, Hermann R, Veijola R, Simell O, Knip M, Ilonen J

2012

 Diabetes

4

61

4

963

966

4

0012-1797

DOIhttps://doi.org/10.2337/db11-0386




Last updated on 26/11/2024 09:46:13 PM